Live News EQUITY L impact Jul 01, 2026, 01:43 PM UTC

Citizens Reiterates Market Outperform on BeOne Medicines, Maintains $396 Price Target

Citizens analyst Reni J. Benjamin reiterates BeOne Medicines (NASDAQ: ONC ) with a Market Outperform and maintains $396 price target.

SQUAWKNEWS Updated Jul 01, 2026, 01:43 PM UTC

Citizens analyst Reni J.

Benjamin reiterates BeOne Medicines (NASDAQ: ONC ) with a Market Outperform and maintains $396 price target.